Sparcero · Fundamentals
Companies / Edwards Lifesciences

Edwards Lifesciences

EW United States
ID 185 · CIK 1099800 · reconciled 2026-10-10T16:43 SEC EDGAR filings ↗ Raw model extractions Employees (legacy)
Revenue FY2025
6.1B
▲ 11.5% vs FY2024
Net profit FY2025
1.1B
▼ 74.4% vs FY2024
Total assets FY2025
13.7B
▲ 4.9% vs FY2024
Stockholders' equity FY2025
10.3B
▲ 3.4% vs FY2024
Operating cash flow FY2025
1.6B
▲ 194.2% vs FY2024
EPS (diluted) FY2025
1.83
▼ 73.7% vs FY2024
Employees FY2025
16,000
▲ 1.3% vs FY2024
Income statementBalance sheetCash flowHuman capital Segments & KPIs Data quality 16
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree) Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree) Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree) Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree) Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.

All entities

Segment data comes from F4: entity names are clustered across models with Qwen, then each period is a majority vote. Unlike F1–F3 there is no 2-model minimum — hover a value to see how many models reported it.

Vote results

SourceValidatedDiscardedCalculatedEmptyDiscard rate
F1 · income statement 1,172137 245413 10.5%
F2 · balance sheet 1,941148 01,079 7.1%
F3 · cash flow 43028 630231 6.1%
F5 · human capital 512 0343 3.8%

Re-run plan for this company

ActionSourceFormPeriod end AccessionTierFieldsMissing models
run missing model F110-K4052001-12-31 0000912057-02-0111881 shares_outstanding, eps_basic, eps_diluted, revenue, income_before_tax, net_profit, cost_of_revenue Qwen3.6-27B-Q8_0, no-ai-xblr
run third ai F110-Q2000-03-31 0000912057-00-0246103 eps_basic[3mo], eps_basic[ytd], eps_diluted[3mo], eps_diluted[ytd] no-ai-xblr
third ai optional F110-Q2003-06-30 0001047469-03-0272644 shares_outstanding no-ai-xblr
run missing model F210-K4052001-12-31 0000912057-02-0111881 cash_and_equivalents, total_current_assets, total_assets, total_current_liabilities, long_term_debt, total_stockholders_equity Qwen3.6-27B-Q8_0, no-ai-xblr
run third ai F210-K2003-12-31 0001047469-04-0077262 total_current_liabilities no-ai-xblr
skip F210-K2011-12-31 0001047469-12-001617 total_liabilities
third ai optional F210-Q2003-06-30 0001047469-03-0272644 long_term_debt no-ai-xblr
third ai optional F210-Q2003-09-30 0001047469-03-0372304 long_term_debt no-ai-xblr
third ai optional F210-Q2004-06-30 0001047469-04-0256284 total_current_liabilities no-ai-xblr
third ai optional F210-Q2004-09-30 0001047469-04-0332614 total_current_liabilities no-ai-xblr
third ai optional F210-Q2005-03-31 0001047469-05-0134044 total_current_liabilities no-ai-xblr
skip F210-Q2011-03-31 0001047469-11-004794 total_liabilities
third ai optional F210-Q2016-06-30 0001099800-16-0000704 total_current_liabilities
third ai optional F210-Q2016-09-30 0001099800-16-0000774 total_current_liabilities
run missing model F310-K4052001-12-31 0000912057-02-0111881 net_cash_provided_by_operating_activities, net_cash_provided_by_financing_activities, net_cash_provided_by_investment_activities, capital_expenditure Qwen3.6-27B-Q8_0, no-ai-xblr
run missing model F510-K4052001-12-31 0000912057-02-0111882 employees_total Qwen3.6-27B-Q8_0, no-ai-xblr